Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NO-NSAIDs licensed by NicOx to Astra for pain and inflammation

Oct. 2, 1998

Potent analgesic agents from HMR with additional pharmacological effects

Oct. 2, 1998

ADIR claims 2-aminoindanes for CNS disorders involving serotonergic system dysfunction

Oct. 2, 1998

Elan invests in Ligand; Ligand obtains certain rights to Morphelan

Oct. 1, 1998

Japanese investigators design novel class of NMDA receptor channel blocker

Oct. 1, 1998

Agents for dementia a focus of R&D at Sanofi

Oct. 1, 1998

Neurogen compounds interacting with CRF1 receptors for stress-related disorders

Oct. 1, 1998

Chirocaine shows increased safety in obstetric population

Sep. 30, 1998

Guilford prototype PARP inhibitor proves effective in animal models of stroke, heart attack

Sep. 30, 1998

PowderJect system effectively delivers local anesthetic without a needle

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...